Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours

This publication has 28 references indexed in Scilit:

• Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours
  European Journal Of Cancer, 1995
• Phase Ib Trial of Granulocyte-Macrophage Colony-Stimulating Factor Combined with Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma
  Journal of Immunotherapy, 1994
• Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1993
• Effect of monoclonal antibody 17‐1A and gm‐CSF in patients with advanced colorectal carcinoma—long‐lasting, complete remissions can be induced
  International Journal of Cancer, 1993
• A PHASE IB TRIAL OF MURINE MONOCLONAL ANTIBODY R24 (ANTI-GD3) IN METASTATIC MELANOMA
  Journal of Immunotherapy, 1992
• Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies
  Cancer Immunology, Immunotherapy, 1991
• Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity
  Journal of Cellular Biochemistry, 1991
• Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A)
  Cancer Immunology, Immunotherapy, 1990
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
  International Journal of Cancer, 1986